SE8904104L - Stereospecifikt foerfarande foer framstaellning av furo/3,4-c/pyridinenantiomerer, de saa erhaallna foereningarna och terapeutiska kompositioner daerav - Google Patents

Stereospecifikt foerfarande foer framstaellning av furo/3,4-c/pyridinenantiomerer, de saa erhaallna foereningarna och terapeutiska kompositioner daerav

Info

Publication number
SE8904104L
SE8904104L SE8904104A SE8904104A SE8904104L SE 8904104 L SE8904104 L SE 8904104L SE 8904104 A SE8904104 A SE 8904104A SE 8904104 A SE8904104 A SE 8904104A SE 8904104 L SE8904104 L SE 8904104L
Authority
SE
Sweden
Prior art keywords
pyridine
furo
preparation
unitiomers
societies
Prior art date
Application number
SE8904104A
Other languages
English (en)
Other versions
SE509130C2 (sv
SE8904104D0 (sv
Inventor
M Bonato
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of SE8904104L publication Critical patent/SE8904104L/sv
Publication of SE8904104D0 publication Critical patent/SE8904104D0/sv
Publication of SE509130C2 publication Critical patent/SE509130C2/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyridine Compounds (AREA)
SE8904104A 1988-04-06 1989-12-05 Stereospecifikt förfarande för framställning av furo/3,4-c/ pyridinenantiomerer SE509130C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808001A GB8808001D0 (en) 1988-04-06 1988-04-06 Stereospecific preparative process for furol(3,4-c)pyridine derivatives
PCT/FR1989/000157 WO1989009772A1 (fr) 1988-04-06 1989-04-06 PROCEDE STEREOSPECIFIQUE POUR LA PREPARATION DES ENANTIOMERES DE LA FURO[3,4-c]PYRIDINE, COMPOSES AINSI OBTENUS ET COMPOSITIONS THERAPEUTIQUES A BASE DE CES COMPOSES

Publications (3)

Publication Number Publication Date
SE8904104L true SE8904104L (sv) 1989-12-05
SE8904104D0 SE8904104D0 (sv) 1989-12-05
SE509130C2 SE509130C2 (sv) 1998-12-07

Family

ID=10634633

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8904104A SE509130C2 (sv) 1988-04-06 1989-12-05 Stereospecifikt förfarande för framställning av furo/3,4-c/ pyridinenantiomerer

Country Status (28)

Country Link
US (1) US5026855A (sv)
EP (1) EP0337858B1 (sv)
JP (1) JP2680456B2 (sv)
KR (1) KR970005308B1 (sv)
AT (1) AT397093B (sv)
AU (1) AU616753B2 (sv)
BE (1) BE1003843A4 (sv)
CA (1) CA1338475C (sv)
CH (1) CH680000A5 (sv)
DK (1) DK167020B1 (sv)
DZ (1) DZ1335A1 (sv)
ES (1) ES2057159T3 (sv)
FI (1) FI93116C (sv)
FR (2) FR2629821B1 (sv)
GB (2) GB8808001D0 (sv)
IE (1) IE61915B1 (sv)
IN (1) IN172987B (sv)
MA (1) MA21529A1 (sv)
MY (1) MY104424A (sv)
NL (1) NL8920307A (sv)
NZ (1) NZ228614A (sv)
OA (1) OA09247A (sv)
PT (1) PT90210B (sv)
SE (1) SE509130C2 (sv)
SG (1) SG40492G (sv)
TN (1) TNSN89043A1 (sv)
WO (1) WO1989009772A1 (sv)
ZA (1) ZA892477B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives
GB8917168D0 (en) * 1989-07-27 1989-09-13 Scras Asymmetric synthesis of furo(3,4-c)pyridine derivatives
US5130252A (en) * 1990-05-14 1992-07-14 Synthetech, Inc. Resolution of furopyridine enantiomers and synthetic precursors thereof
US20060089374A1 (en) * 2003-07-17 2006-04-27 Glenn Cornett Enantiomeric compositions of cicletanine, alone and in combination with other agents, for the treatment of disease
GB2423927A (en) * 2003-08-29 2006-09-13 Cotherix Inc Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome
US20060154959A1 (en) * 2005-01-13 2006-07-13 Navitas Pharma Combination therapies of cicletanine and carvedilol
US20080096915A1 (en) * 2005-01-13 2008-04-24 Greenberg Traurig LLP Compositions for the treatment of metabolic disorders
US20070141174A1 (en) * 2005-01-13 2007-06-21 Navitas Pharma, Inc. Enantiomeric compositions of cicletanine, in combination with other agents, for the treatment of hypertension
US20070105817A1 (en) * 2005-11-09 2007-05-10 Jim Page Use of cicletanine and other furopyridines for treatment of systolic-predominant hypertension, isolated systolic hypertension, elevated pulse pressure, and general hypertension
JP2010514841A (ja) * 2007-01-03 2010-05-06 グレン ブイ． コルネット， 肺疾患および心疾患の処置におけるシクレタニンおよびｐｋｃ阻害剤
AR073259A1 (es) * 2008-07-29 2010-10-28 Merck & Co Inc Derivados de furosemida utiles como diureticos
US8377911B2 (en) 2009-10-09 2013-02-19 Merck Sharp & Dohme Corp. Diuretics
WO2015103445A1 (en) * 2013-12-31 2015-07-09 Rockey Don C Systems, methods, techniques, and compounds in research and treatment of portal hypertension and other conditions

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IN156817B (sv) * 1981-02-10 1985-11-09 Scras
IN160104B (sv) * 1983-04-05 1987-06-27 Scras
US4735950A (en) * 1983-04-05 1988-04-05 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S) Furo-(3,4-C)-pyridine derivatives and therapeutic composition containing the same
ZA842029B (en) * 1983-04-05 1984-10-31 Scras Furo-(3,4-c)-pyridine derivatives preparation thereof and therapeutic compositions containing the same
GB2137618B (en) * 1983-04-05 1986-05-08 Scras Furo-(3,4-c)-pyridine derivatives
GB8327817D0 (en) * 1983-10-18 1983-11-16 Scras 4-halo-furo-(3 4-c)-pyridine derivatives
GB8330517D0 (en) * 1983-11-16 1983-12-21 Scras 6-vinyl-furo-(3,4-c)pyridine derivatives
GB8330658D0 (en) * 1983-11-17 1983-12-29 Scras 7-carboxymethoxy-furo-(3,4-c)-pyridine derivatives
GB8402740D0 (en) * 1984-02-02 1984-03-07 Scras Furo-(3 4-c)-pyridine derivatives
GB8414559D0 (en) * 1984-06-07 1984-07-11 Scras Pyridine derivatives
GB8422029D0 (en) * 1984-08-31 1984-10-03 Scras 6-substituted-furo-(3 4-c)-pyridine derivatives
GB8422379D0 (en) * 1984-09-05 1984-10-10 Scras Derivatives
GB8427218D0 (en) * 1984-10-27 1984-12-05 Scras Pyridine derivatives
DE3519693A1 (de) * 1985-06-01 1987-01-02 Basf Ag Pyridin-derivate, ihre herstellung und verwendung
GB8808001D0 (en) * 1988-04-06 1988-05-05 Scras Stereospecific preparative process for furol(3,4-c)pyridine derivatives
GB8907480D0 (en) * 1989-04-03 1989-05-17 Scaras Societe De Conseils De Separation of insomers of furo(3,4-c)pyridine derivatives

Also Published As

Publication number Publication date
PT90210A (pt) 1989-11-10
AT397093B (de) 1994-01-25
AU3419089A (en) 1989-11-03
JPH02504394A (ja) 1990-12-13
FR2629820A1 (fr) 1989-10-13
FI93116B (sv) 1994-11-15
SG40492G (en) 1992-06-12
FI93116C (sv) 1995-02-27
IN172987B (sv) 1994-01-15
FR2629821B1 (fr) 1993-12-03
DK611689A (da) 1989-12-05
GB2235194B (en) 1992-01-29
DK167020B1 (da) 1993-08-16
FR2629821A1 (fr) 1989-10-13
BE1003843A4 (fr) 1992-06-30
FI895826A0 (sv) 1989-12-05
ES2057159T3 (es) 1994-10-16
DK611689D0 (da) 1989-12-05
KR970005308B1 (ko) 1997-04-15
NL8920307A (nl) 1990-03-01
CA1338475C (en) 1996-07-23
TNSN89043A1 (fr) 1991-02-04
WO1989009772A1 (fr) 1989-10-19
SE509130C2 (sv) 1998-12-07
EP0337858B1 (fr) 1994-06-08
FR2629820B1 (fr) 1993-12-03
US5026855A (en) 1991-06-25
ATA900589A (de) 1993-06-15
KR900700483A (ko) 1990-08-13
SE8904104D0 (sv) 1989-12-05
EP0337858A1 (fr) 1989-10-18
IE891076L (en) 1989-10-06
MY104424A (en) 1994-03-31
GB8927509D0 (en) 1990-06-13
DZ1335A1 (fr) 2004-09-13
AU616753B2 (en) 1991-11-07
GB2235194A (en) 1991-02-27
IE61915B1 (en) 1994-11-30
MA21529A1 (fr) 1989-12-31
PT90210B (pt) 1994-06-30
CH680000A5 (sv) 1992-05-29
JP2680456B2 (ja) 1997-11-19
NZ228614A (en) 1990-11-27
OA09247A (fr) 1992-06-30
ZA892477B (en) 1989-12-27
GB8808001D0 (en) 1988-05-05

Similar Documents

Publication Publication Date Title
SE8904104L (sv) Stereospecifikt foerfarande foer framstaellning av furo/3,4-c/pyridinenantiomerer, de saa erhaallna foereningarna och terapeutiska kompositioner daerav
HU906402D0 (en) Process for producing tricyclic carbapeneme derivatives an pharmaceutical preparatives containing these compounds as active substance
NO162518C (no) Analogifremgangsmaate for fremstilling av nye, terapeutiskaktive 8-klor-1,5-benzothiazepinderivater.
ATE25981T1 (de) 6-amino-7-hydroxy-4,5,6,7-tetrahydroimidazo(4,5 1-j,k)(1)benzazepin-2(1h)-onderivate, ihre salze, ihre herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
HU9301197D0 (en) Medical preparatives containing quinoline and quinazoline derivatives as well as new quinoline and quinazoline derivatives
DE69011913T2 (de) Phthalinidderivat, pharmazeutische Zubereitung und Verwendung.
OA07586A (fr) Acide 6,7-dihydro-5,8-diméthyl-9-floro-1-oxo-1H,5H-benzo (ij)quinolizine-2-carboxylique et ses dérivés et leur procédé de préparation.
AU1507888A (en) New bicyclic compounds, processes for preparation thereof and pharmaceutical composition comprising the same
NZ238009A (en) Preparation of enantiomers of furo(3,4-c)pyridine derivatives
AU584157B2 (en) Urea derivatives
ES8106516A1 (es) Procedimiento de preparacion de nuevos derivados halovinca- monas y de sus sales de adicion acidas farmaceuticamente aceptables e isomeros opticamente activos de los mismos
FR2378781A1 (fr) Nouveaux derives d'alcaloides de l'ergot de seigle, leur preparation et leur application comme medicaments
DE68905363T2 (de) Heterotetracyclische laktamderivate, verfahren zu ihrer herstellung und pharmazeutische zubereitungen, die sie enthalten.
EP0250755A3 (en) Fluorine derivatives of vitamin d3 and process for producing the same
IE850161L (en) Penem derivatives and azetidinone intermediates
NO165593C (no) Analogifremgangsmaate ved fremstilling av nye tetracykliske indolderivater.
AU657423B2 (en) Novel piperidine derivatives and process for preparation thereof
IE890199L (en) Antibiotic a 42867 derivative
HUT40094A (en) Process for preparing heteropolycyclyc aromatic alkanole derivatives and pharmaceutical compositions containing the same
HUT48615A (en) Process for producing dibenzo/b, e/oxepinacetic acid derivatives and pharmaceutical compositions comprising such compounds
ES8105713A1 (es) Un procedimiento para la preparacion de los enatiomeros levogiro y dextrogiro de la 1-ciclopropil-metil-4-(3-metoxi-5h- dibenzo (a,d) ciclohepten-5-iliden) piperidina

Legal Events

Date Code Title Description
NUG Patent has lapsed